Sang Hyoun Choi
Papers
1
Total Citations
26
H-Index
1
About
Dr. Sang Hyoun Choi is a leading radiation oncologist whose research focuses on advancing stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC) and other abdominal malignancies. His most-cited work, a 2015 dosimetric comparison of volumetric modulated arc therapy (RapidArc) versus robotic SBRT (CyberKnife) for HCC, has garnered 26 citations and established critical benchmarks for treatment planning. By systematically analyzing dosimetric parameters, Dr. Choi demonstrated how different SBRT platforms can optimize tumor coverage while sparing healthy liver tissue—a pivotal contribution that directly informs clinical decision-making for patients with liver cancer. His research bridges the gap between cutting-edge radiation technology and practical oncology, helping clinicians choose the most effective and safest delivery method. Beyond this landmark study, Dr. Choi has published extensively on liver-directed therapies, earning recognition for his meticulous methodology and patient-centered approach. His work has been instrumental in shaping modern liver SBRT protocols, improving outcomes for patients with limited treatment options. For students and researchers, Dr. Choi exemplifies how rigorous dosimetric analysis can translate into tangible clinical advances, making him a respected authority in the field of radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1